Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jack Whelan

Jack Whelan

Research Advocate,Cancer survivor warrior, USA

Title: e-Patient’s Perspective path to survival monitoring own biomarkers during Clinical Trials using Real World Evidence and Risk Based Monitoring.

Biography

Biography: Jack Whelan

Abstract

Jack Whelan an eight-year survivor of a rare, incurable blood cancer, recently diagnosed with an aggressive metastatic prostate cancer has moved from a career as IT Research Analyst to Research Advocate. Travel with Jack on an intensely personal and humorous bumpy ride on the road to Personalized Medicine still under construction while he is treated for his cancers. Hear his compelling, hopeful and helpful e-Patient observations about how to improve health care using some latest generation Information Technology. Come away with some unique insight that will change your assumptions about research and health IT; get new actionable ideas about how to begin to harness real world data to improve outcomes for patients as we seek safer more effective therapeutics using Advanced Analytics.A tireless Advocate he’s an active with American Association for Cancer Research, received AACR’s 2017 Distinguished Public Service Award, American Society of Clinical Oncology, the NCI’s National Clinical Trials Network, Rare Disease Legislative Advocacy and other professional research and legislative advocacy groups. Jack hopes all of us appreciate the value and noble work of life sciences employees and companies involved in cancer research and care. A decided friend to BioPharma as an engaged, informed e-Patient Opinion Leader (POL) and advocate he regularly speaks to and for these companies, to open much-needed, lines of communications with patients, providers and policymakers.Jack understands the realities of his rare blood and metastatic prostate cancers as he has repeatedly relapsed and has been refractory to many of the therapies received thus far; however his goal is repeated periods of progression free survival during which the promise of science and delivery of successful therapeutics will be achieved. His website is located at Jack-Whelan.com